ReviewCurrent treatment options in cardiovascular medicine2017

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Its Inhibitors: a Review of Physiology, Biology, and Clinical Data.

Ashwin Durairaj et al.PubMed ↗Publisher ↗

No numbers read from the abstract.